Degrees Pharmaceuticals (SXTP) announced that it will effect a 1-for-5 reverse stock split of its common stock. The common stock will ...

Innate Pharma shares were up 16% to $2.25 after the company said the Food and Drug Administration has granted Breakthrough Therapy Designation to lacutamab for the treatment of adult patients with ...

Explore Sun Pharma Industries stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the ...

A bipartisan coalition of states, including Tennessee, will receive $7.4 billion from Purdue Pharma, Inc. and members of the Sackler family for their “instrumental” role in the crisis.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

That is why the $7.4 billion settlement by Purdue Pharma is so important. Purdue Pharma, owners could pay $7.4 billion in new settlement over toll of OxyContin Connecticut will get more than $60 ...

NEW YORK (Reuters) - Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the company's years-long effort to resolve thousands of ...

Bankrupt Purdue Pharma and its owners have agreed to pay $7.4 billion (€7.1 billion) to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

In a multi-billion dollar settlement, New York State stands to receive up to $250 million from Purdue Pharma and the family at the helm of the company, the Sacklers. Purdue Pharma is behind the ...